NaviStar Thermo Cool catheter

New Jersey, February 9: Johnson & Johnson unit Biosense Webster got a nod from the Food and Drug Administration (FDA) Friday to sell a device known as the ‘NaviStar Thermo Cool’ catheterdefine. The device is used in the treatment of the common heart-rhythm disorder ‘atrial fibrillation’.

With the approval in its kitty, Biosense Webster will compete with the likes of St. Jude Medical Inc., Medtronic Inc. and Boston Scientific Corp. and vie for a share in an already fast-growing cardiacdefine medical device market. Analysts claim that the heart-ablation market may reach $2 billion in annual sales by 2011.